SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001588968-20-000001
Filing Date
2020-10-22
Accepted
2020-10-22 13:23:30
Documents
1
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 5  
1 PRIMARY DOCUMENT primary_doc.xml 5 1689
  Complete submission text file 0001588968-20-000001.txt   3172
Mailing Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404
Business Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404 310-444-4300
BIOVIE INC. (Issuer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CYMABAY THERAPEUTICS, INC. 3876 BAY CENTER PLACE HAYWARD CA 94545
Business Address
Kumar Hari (Reporting) CIK: 0001588968 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-39015 | Film No.: 201253554